Serum from women with polycystic ovary syndrome inhibits fertilization and embryonic development in the murine in vitro fertilization model
- 1 June 1996
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 65 (6) , 1224-1228
- https://doi.org/10.1016/s0015-0282(16)58343-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- In vitro fertilization of androgen sterilized miceLife Sciences, 1994
- Effect of diabetes mellitus on mouse pre-implantation embryo developmentReproduction, 1991
- Hypersecretion of luteinising hormone, infertility, and miscarriageThe Lancet, 1990
- HORMONAL PROFILES FOLLOWING CLOMIPHENE CITRATE THERAPY IN CONCEPTION AND NONCONCEPTION CYCLESClinical Endocrinology, 1990
- HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME: CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTSClinical Endocrinology, 1989
- Effects of an Antiandrogen, Flutamide, on Oocyte Quality and Embryo Development in Rats Superovulated with Pregnant Mare’s Serum Gonadotropin1Biology of Reproduction, 1988
- Clomiphene Citrate-Initiated Ovulation: A Clinical UpdateSeminars in Reproductive Medicine, 1986
- Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phaseBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Ovarian Steroid Secretion in Polycystic Ovarian DiseaseSeminars in Reproductive Medicine, 1984
- Gonadotropin Secretion in Polycystic Ovary DiseaseSeminars in Reproductive Medicine, 1984